International stock news

Rss Today on Proactive AU

2014-11-27

Imugene is undervalued v ASX, global peers in Immuno-Oncology

 
Imugene is an immuno-oncology company developing B-cell based immunotherapies. Immunotherapy has become one of the hottest and most promising areas of study for the treatment of a variety of cancerous tumours. Pfizer and Merck will JV on up to 20 preclinical immuno-oncology programs in 2015.
FULL ARTICLE

 

Rss Today on Proactive UK

2014-11-27

Stratex deserves more credit for impending production, says broker

 
Setting a 12p per share price target, Stratex’s house broker based its assessment on the ‘imminent commissioning’ of the Altintepe mine.
FULL ARTICLE

 

Rss Today on Proactive US

2014-11-27

Dow, S&P 500 finish at records pre-Turkey Day

 
U.S. stocks edged up amid thin volumes Wednesday after a deluge of data, including a spike in initial jobless claims, a jump in durable goods and lower-than-anticipated consumer spending and new home sales. Both the S&P 500 and the Dow managed to clinch new records.
FULL ARTICLE